Cellular and molecular mechanisms of regulation of autoantibody production in lupus

被引:38
作者
Hahn, BH
Ebling, F
Singh, RR
Singh, RP
Karpouzas, G
La Cava, AA
机构
[1] Univ Calif Los Angeles, Div Rheumatol, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH USA
[3] Harbor UCLA Med Ctr, Torrance, CA 90509 USA
来源
AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS | 2005年 / 1051卷
关键词
systemic lupus erythematosus; CD8(+) T cells; regulatory T cells; suppressor T cells;
D O I
10.1196/annals.1361.085
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The hyperactive interaction between helper T cells and autoimmune B cells in individuals predisposed to systemic lupus erythematosus (SLE) can be interrupted by induction of regulatory and suppressor T cells. Using two strategies-high dose tolerance to an immunoglobulin-derived peptide, and minigene vaccination with DNA encoding T cell epitopes presented by MHC class I molecules-our group has induced at least three types of regulatory/suppressive T cells. They include CD8(+) T cells that suppress helper T cells by cytokine secretion, CD8+ T suppressors that kill B cells making anti-DNA antibodies, and peptide-binding CD4(+)CD25(+) regulatory T cells that suppress B cells by direct cell contact. Each of these lymphocyte subsets suppresses anti-DNA antibody production and delays the onset of nephritis in BWF1 lupus-prone mice. Patients with SLE have amino acid sequences similar to those from murine anti-DNA antibodies used in these studies, and at similar locations in the VH regions of anti-DNA immunoglobulins. Therefore, strategies described here might ultimately be useful in therapy of the human disease.
引用
收藏
页码:433 / 441
页数:9
相关论文
共 32 条
  • [1] Boden Elisa, 2003, Novartis Found Symp, V252, P55
  • [2] CONNOLLY DJ, 1993, J IMMUNOL, V151, P6089
  • [3] Quantification of regulatory T cells in patients with systemic lupus erythematosus
    Crispin, JC
    Martínez, A
    Alcocer-Varela, J
    [J]. JOURNAL OF AUTOIMMUNITY, 2003, 21 (03) : 273 - 276
  • [4] Vaccination with minigenes encoding VH-derived major histo compatibility complex class I-binding Epitopes activates cytotoxic T cells that ablate autoantibody-producing B cells and inhibit lupus
    Fan, GC
    Singh, RR
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) : 731 - 741
  • [5] Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function
    Filaci, G
    Fravega, M
    Negrini, S
    Procopio, F
    Fenoglio, D
    Rizzi, M
    Brenci, S
    Contini, P
    Olive, D
    Ghio, M
    Setti, M
    Accolla, RS
    Puppo, F
    Indiveri, F
    [J]. HUMAN IMMUNOLOGY, 2004, 65 (02) : 142 - 156
  • [6] Impairment of CD8+ T suppressor cell function in patients with active systemic lupus erythematosus
    Filaci, G
    Bacilieri, S
    Fravega, M
    Monetti, M
    Contini, P
    Ghio, M
    Setti, M
    Puppo, F
    Indiveri, F
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (10) : 6452 - 6457
  • [7] Characteristics of T cells that participate in the pathogenesis of SLE
    Hahn, B
    Datta, S
    [J]. LUPUS, 1997, 6 (03) : 330 - 332
  • [8] Hahn BH, 2001, ARTHRITIS RHEUM-US, V44, P432, DOI 10.1002/1529-0131(200102)44:2<432::AID-ANR62>3.0.CO
  • [9] 2-S
  • [10] Control of regulatory T cell development by the transcription factor Foxp3
    Hori, S
    Nomura, T
    Sakaguchi, S
    [J]. SCIENCE, 2003, 299 (5609) : 1057 - 1061